Crohn Jejunoileitis C5686428
Crohn jejunoileitis is Crohn's disease affecting both the middle and end of the small intestine. It leads to inflammation, pain, and difficulty absorbing nutrients. Treatment focuses on reducing inflammation and managing symptoms.
Key facts at a glance
- ICD-10
- K76.9
- ICD-11
- DA00.0
- Body system
- gastrointestinal
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Fever
Abdominal pain
(gastrointestinal)Abdominal pain or nausea
(gastrointestinal)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diarrhea
(gastrointestinal)Night sweats
(gastrointestinal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Biologic therapy (anti-TNF)
Anti-tumor necrosis factor agents such as infliximab or adalimumab to induce and maintain remission in moderate to severe jejunoileitis.
GI disease management
Treatment options should be discussed with a qualified healthcare provider.
Low-residue nutritional therapy
Dietary modification to reduce fiber and bulk, minimizing obstruction risk in patients with stricturing jejunoileitis patterns.
Additional treatment options
Strictureplasty
Surgical technique to widen narrowed intestinal segments while preserving bowel length in patients with symptomatic strictures.
surgicalBalloon dilation
Endoscopic balloon dilation of short strictures to relieve obstruction symptoms and delay need for surgical intervention.
procedureNutritional status assessment
Regular monitoring of albumin, vitamin levels, and bone density to detect and treat malnutrition and osteopenia from malabsorption.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Crohn Jejunoileitis C5686428?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Sanderson JD, Smith CJ, Greenwald RM. British Society of Gastroenterology Consensus Guidelines for the Management of Crohn's Disease. Gut. 2021.
Baumgart DC, Carding SR. Crohn's disease: diagnosis and management. Lancet. 2020.
Colombel JF, Reinisch W, Mandell K, et al. Comparative Efficacy of Biologic Therapies in Moderate-to-Severe Crohn's Disease: Results from the EXTEND Trial. Gastroenterology. 2022.
Singh S, Murad MH, Fumery M, et al. Comparative Effectiveness of Immunomodulators and Biologics for Induction and Maintenance of Remission in Crohn's Disease: A Systematic Review and Network Meta-Analysis. Clin Gastroenterol Hepatol. 2019.
Medication Comparisons
Compare medications used to treat Crohn Jejunoileitis C5686428. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy